Marc Scheineson is quoted on the wide berth provided to drug and device product manufacturers by the U.S. Food and Drug Administration and the Federal Trade Commission on disease awareness communications.
In the News
February 8, 2019
Bloomberg Law | ‘Keep Her Awesome’ to Sleep Campaigns Skirt Drug-Ad Rules
Media Contact